Lista de obras - Lars Wallentin - Dominio Público Uruguay

2008 National Cardiology Guidelines: Prioritization requires consideration to other factors than scientific studies alone

artículo científico publicado en 2008

5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study

artículo científico publicado en 2006

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

artículo científico publicado en 2017

A catalog of genetic loci associated with kidney function from analyses of a million individuals

scientific article published on 31 May 2019

A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy

artículo científico publicado en 2005

A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors

artículo científico publicado en 2017

A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study

artículo científico publicado en 2002

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

artículo científico publicado en 2002

A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes

artículo científico publicado en 2004

ABSTRACTS

scholarly article

ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial

scientific article published on 29 November 2019

Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy

artículo científico publicado en 2004

Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease

artículo científico publicado en 1999

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy

artículo científico publicado en 2004

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST–elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy11Guest Editor for this manuscript

article by Stefan K James et al published February 2004 in American Heart Journal

Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK.

artículo científico publicado en 2014

Additional events in the RE-LY trial

artículo científico publicado en 2014

Additional value of thallium-201 SPECT to a conventional exercise test for the identification of severe coronary lesions after an episode of unstable coronary artery disease

artículo científico publicado en 1995

Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes

artículo científico publicado en 2019

Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction

artículo científico publicado en 2005

Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction

scientific article published on 01 January 2004

Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey

artículo científico publicado en 2006

Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS

artículo científico publicado en 2006

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

artículo científico publicado en 2016

All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome

artículo científico publicado en 2016

Ambulatory ST-recording has no additional value to exercise test for identification of severe coronary lesions after an episode of unstable coronary artery disease in men

artículo científico publicado en 1993

Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial

artículo científico publicado en 2014

An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease

artículo científico publicado en 2005

An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome

artículo científico publicado en 2017

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study

artículo científico publicado en 2004

Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

artículo científico publicado en 2016

Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial

artículo científico publicado en 2015

Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies

artículo científico publicado en 2007

Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)

article

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

scientific article published on 27 September 2020

Antibodies against MYC-Associated Zinc Finger Protein: An Independent Marker in Acute Coronary Syndrome?

artículo científico publicado en 2017

Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial

artículo científico publicado en 2015

Anticoagulants in heart disease: current status and perspectives

artículo científico publicado en 2007

Anticoagulation Therapy in Atrial Fibrillation in Combination With Acute Myocardial Infarction Influences Long-Term Outcome

artículo científico publicado en 2005

Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial

artículo científico publicado en 2016

Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?

artículo científico publicado en 2014

Antithrombotic Therapy Use and Clinical Outcomes Following Thromboembolic Events in Patients with Atrial Fibrillation: Insights from ARISTOTLE.

artículo científico publicado en 2018

Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005.

artículo científico publicado en 2008

Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention

artículo científico publicado en 2017

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis.

artículo científico publicado en 2018

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

artículo científico

Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative

artículo científico publicado en 2008

Antithrombotics in acute coronary syndromes

artículo científico publicado en 2009

Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial

artículo científico

Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial.

artículo científico publicado en 2015

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

artículo científico publicado en 2012

Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial

artículo científico publicado en 2017

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

artículo científico publicado en 2010

Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trial

artículo científico publicado en 2013

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease

artículo científico publicado en 2020

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

artículo científico publicado en 2013

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

artículo científico publicado en 2013

Apixaban with antiplatelet therapy after acute coronary syndrome

artículo científico publicado en 2011

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

artículo científico publicado en 2009

Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation

artículo científico publicado en 2016

Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis

artículo científico publicado en 2005

Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

artículo científico publicado en 2009

Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction

scientific article published in The Journal of the American Medical Association

Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction

artículo científico publicado en 2011

Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction

artículo científico publicado en 2015

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

artículo científico publicado en 2019

Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation

scientific article published on 31 August 2020

Association of Factor V Leiden with Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data

artículo científico publicado en 2020

Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study

scientific article published on 01 December 2018

Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).

artículo científico publicado en 2013

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

artículo científico publicado en 2014

Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial

artículo científico

Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS

artículo científico publicado en 2004

Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial

artículo científico publicado en 2014

Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention

article

Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

artículo científico publicado en 2017

Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy

artículo científico publicado en 2018

Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation

artículo científico publicado en 2013

Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes

artículo científico publicado en 2017

Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial

artículo científico publicado en 2012

Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization

artículo científico publicado en 2002

Biochemical indicators of cardiac and renal function in a healthy elderly population

artículo científico publicado en 2004

Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

artículo científico publicado en 2017

Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome

artículo científico publicado en 2016

Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial

artículo científico publicado en 2015

Biomarkers in atrial fibrillation: a clinical review

artículo científico

Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibi

artículo científico

Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation

artículo científico

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

artículo científico publicado en 2017

Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial).

artículo científico publicado en 2016

Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction

artículo científico publicado en 2018

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2011

Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.

artículo científico publicado en 2004

Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

artículo científico publicado en 2015

Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease

scientific article published on 01 August 2001

C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes

scientific article published on 26 September 2019

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial

Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy

artículo científico publicado en 2012

Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial

scientific article published on 30 April 2020

CardioScape mapping the cardiovascular funding landscape in Europe.

artículo científico publicado en 2017

Cardiovascular Medicine in Sweden: Improvement by Continuous Measuring

scientific article published on 06 April 2020

Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment

artículo científico publicado en 2010

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial

artículo científico publicado en 2014

Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial

scientific article published on 08 May 2020

Cardiovascular risk factors and clinical presentation in acute coronary syndromes

artículo científico publicado en 2005

Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study

artículo científico publicado en 2013

Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes

artículo científico publicado en 2014

Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals

artículo científico publicado en 2013

Changes in Renal Function in Patients With Atrial Fibrillation: An Analysis From the RE-LY Trial

artículo científico publicado en 2015

Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome

artículo científico publicado en 2015

Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)

scientific article published on 07 August 2019

Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis

scientific article published on 26 March 2020

Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial

artículo científico publicado en 2018

Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes

article

Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban--an oral, direct and selective factor Xa inhibitor

artículo científico publicado en 2011

Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.

artículo científico publicado en 2015

Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay

artículo científico publicado en 2006

Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial

artículo científico publicado en 2017

Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial

artículo científico publicado en 2020

Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy

artículo científico publicado en 2003

Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial

artículo científico publicado en 2019

Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

artículo científico publicado en 2014

Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

artículo científico publicado en 2017

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

artículo científico

Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial

artículo científico publicado en 2015

Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial

artículo científico publicado en 2015

Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy)

artículo científico publicado en 2002

Clopidogrel and warfarin: absence of interaction in patients receiving long-term anticoagulant therapy for non-valvular atrial fibrillation

artículo científico publicado el 1 de mayo de 2003

Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Eval

artículo científico publicado en 2010

Common variants associated with plasma triglycerides and risk for coronary artery disease

artículo científico publicado en 2013

Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block

artículo científico publicado en 2004

Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients from 12 Randomized Trials

artículo científico publicado en 2020

Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram

artículo científico publicado en 2000

Comparison of Cardiac Troponins I and T Measured with High-Sensitivity Methods for Evaluation of Prognosis in Atrial Fibrillation: An ARISTOTLE Substudy

Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial).

artículo científico publicado en 2015

Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy).

artículo científico

Comparison of Platelet Reactivity in Black Versus White Patients With Acute Coronary Syndromes After Treatment With Ticagrelor.

artículo científico publicado en 2017

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial

artículo científico publicado en 2017

Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis.

artículo científico publicado en 2014

Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial

artículo científico

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

artículo científico publicado en 2006

Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registries

artículo científico publicado en 2015

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

artículo científico publicado en 2010

Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) tria

artículo científico publicado en 2009

Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation

artículo científico publicado en 2018

Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

artículo científico publicado en 2012

Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3. A FRISC II substudy

artículo científico publicado en 2005

Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)

scientific article published on 28 August 2015

Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study

artículo científico

Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study

artículo científico publicado en 2011

Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study

artículo científico publicado en 2013

Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome

artículo científico publicado en 2004

D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy.

artículo científico publicado en 2016

D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial

artículo científico publicado en 2014

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation

artículo científico publicado en 2010

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

artículo científico publicado en 2010

Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial

artículo científico publicado en 2013

Dabigatran etexilate and reduction in serum apolipoprotein B

artículo científico publicado en 2015

Dabigatran versus warfarin in patients with atrial fibrillation

artículo científico publicado en 2009

Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation

artículo científico

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial

artículo científico publicado en 2011

Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study

artículo científico

Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).

artículo científico publicado en 2007

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

article

Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)

artículo científico publicado en 2022

Daylight saving time shifts and incidence of acute myocardial infarction--Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).

artículo científico publicado en 2012

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

artículo científico publicado en 2017

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

artículo científico publicado en 2016

Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndrom

artículo científico publicado en 2005

Development of myocardial microcirculation and metabolism in acute ST-elevation myocardial infarction evaluated with positron emission tomography

artículo científico publicado en 2005

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization

artículo científico publicado en 2004

Diagnostic and prognostic importance of ST recording after an episode of unstable angina or non-Q-wave myocardial infarction ⬇️

artículo científico publicado el 1 de febrero de 1992

Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

artículo científico publicado en 2016

Differences between acute myocardial infarction and unstable angina: a longitudinal cohort study reporting findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA).

artículo científico publicado en 2013

Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life

Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome

artículo científico publicado en 2017

Digoxin and Mortality in Patients With Atrial Fibrillation.

artículo científico publicado en 2018

Discovery and refinement of loci associated with lipid levels

artículo científico publicado en 2013

Documentation of study medication dispensing in a prospective large randomized clinical trial: experiences from the ARISTOTLE Trial

Documento de Consenso de Expertos sobre el uso de agentes antiplaquetarios

scientific article published on 01 October 2004

Dynamic vectorcardiography for early diagnosis of acute myocardial infarction compared with 12-lead electrocardiogram. BIOMACS Study Group

scientific article published on 01 December 1996

ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.

artículo científico publicado en 2008

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

artículo científico publicado en 2012

Early angiography in patients with chronic kidney disease: a collaborative systematic review

artículo científico publicado en 2009

Early assessment of long-term risk with continuous ST-segment monitoring among patients with unstable coronary syndromes. Results from 1-year follow-up in the TRIM study

scientific article published on 01 April 2001

Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis ⬇️

artículo científico publicado el 1 de octubre de 1997

Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial

artículo científico publicado en 2007

Early diagnosis and exclusion of acute myocardial infarction by two hours' vector-ECG and determination of either myoglobin or CK-mb. BIOMACS-study. BIOchemical Markers in Acute Coronary Syndromes

artículo científico publicado en 2000

Early exercise testing after coronary care for suspected unstable coronary artery disease--safety and diagnostic value

scientific article published on 01 July 1986

Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease

artículo científico publicado en 2006

Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study

artículo científico publicado en 2016

Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis

artículo científico publicado en 2008

Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study

artículo científico publicado en 2002

Early statin treatment following acute myocardial infarction and 1-year survival

artículo científico publicado en 2001

Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin

artículo científico publicado en 2017

Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial

artículo científico

Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study

artículo científico publicado en 2015

Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction

artículo científico publicado en 2010

Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect

artículo científico publicado en 2017

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

artículo científico publicado en 2010

Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

artículo científico publicado en 2016

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation

scientific article published on 12 September 2018

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

artículo científico publicado en 2015

Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial

artículo científico publicado en 2013

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial

artículo científico publicado en 2013

Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events

artículo científico publicado en 2016

Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-

artículo científico publicado en 2011

Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease

artículo científico publicado en 2003

Effects of apixaban compared with warfarin as gain in event-free time - a novel assessment of the results of the ARISTOTLE trial

scientific article published on 07 November 2019

Effects of dabigatran according to age in atrial fibrillation

artículo científico publicado en 2017

Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment

artículo científico publicado en 2007

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

artículo científico

Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

artículo científico publicado en 2018

Effects of the platelet inhibitor ticlopidine on exercise tolerance in stable angina pectoris

artículo científico publicado en 1987

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial

artículo científico

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial

artículo científico

Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight

artículo científico publicado en 2019

Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial.

artículo científico publicado en 2017

Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

artículo científico publicado en 2015

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

artículo científico publicado en 2014

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.

artículo científico publicado en 2012

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.

artículo científico publicado en 2013

Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE

scientific article published on 06 June 2014

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial

scientific article published on 09 April 2019

Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study

artículo científico publicado en 2012

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

artículo científico publicado en 2010

Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time-A RE-LY trial analysis

artículo científico publicado en 2018

Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis

artículo científico

Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trial.

artículo científico publicado en 2011

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial

artículo científico publicado en 2007

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomi

artículo científico publicado en 2003

Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)

Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data

artículo científico publicado en 2006

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

artículo científico publicado en 2012

Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction

artículo científico publicado en 2004

Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women

artículo científico publicado en 2007

Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study

artículo científico publicado en 2018

EuroHeart: European Unified Registries On Heart Care Evaluation and Randomized Trials

artículo científico publicado en 2019

European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes

artículo científico publicado en 2020

Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes. A panel discussion with audience participation

artículo científico publicado en 2001

Evaluation of Temporal Changes in Cardiovascular Biomarker Concentrations Improves Risk Prediction in an Elderly Population from the Community

artículo científico publicado en 2016

Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

scientific article published on 01 September 2020

Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits

artículo científico publicado en 2016

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology

artículo científico publicado en 2004

Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2014

Extracellular vesicles in atrial fibrillation and stroke

artículo científico publicado en 2020

Factors Contributing to the Lower Mortality With Ticagrelor Compared With Clopidogrel in Patients Undergoing Coronary Artery Bypass Surgery

article

Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials

scientific article published on 29 November 2018

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy ⬇️

artículo científico publicado en 2018

Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort

artículo científico publicado en 2003

Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction

artículo científico publicado en 2006

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials

scientific article published on 01 February 2019

From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes: JACC State-of-the-Art Review

artículo científico publicado en 2019

From European to National guidelines on heart disease ⬇️

artículo científico publicado el 6 de diciembre de 2010

GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men

artículo científico publicado en 2013

Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

artículo científico publicado en 2019

Gender differences in management and outcome in non-ST-elevation acute coronary syndrome

artículo científico publicado en 2006

Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction

artículo científico publicado en 2010

General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.

artículo científico publicado en 2013

Genetic determinants of dabigatran plasma levels and their relation to bleeding

artículo científico publicado en 2013

Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy

artículo científico publicado en 2016

Genetic substudy of the PLATO trial – Authors' reply

artículo científico publicado en 2011

Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome

scientific article published on 16 June 2006

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease

artículo científico publicado en 2009

Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes

artículo científico publicado en 2005

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome

artículo científico publicado en 2015

Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome

artículo científico publicado en 2016

Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

artículo científico publicado en 2020

Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk

artículo científico publicado en 2017

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).

artículo científico publicado en 2015

Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease

scientific article published on 01 October 2008

Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

artículo científico publicado en 2016

Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease

artículo científico publicado en 2016

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding

artículo científico publicado en 2017

Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non ST-Elevation Acute Coronary Syndrome

article by K. C. Wollert et al published 2 October 2007 in Circulation

Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARI

artículo científico

Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22

scientific article published on 21 October 2010

Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study

artículo científico publicado en 2015

Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

artículo científico publicado en 2017

Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain

artículo científico publicado en 2008

Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome

scientific article published on 11 December 2009

Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction

artículo científico publicado en 2007

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

artículo científico publicado en 2009

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

artículo científico publicado en 2007

Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST

Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy

artículo científico publicado en 2014

Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trial

artículo científico publicado en 2013

Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial

artículo científico publicado en 2020

High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction

artículo científico publicado en 2015

High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men.

artículo científico publicado en 2013

High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

artículo científico publicado en 2013

High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin

artículo científico publicado en 2013

Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil

artículo científico publicado en 2011

History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.

artículo científico publicado en 2016

Hospital therapy traditions influence long-term survival in patients with acute myocardial infarction

artículo científico publicado en 2005

How can we optimize the processes of care for acute coronary syndromes to improve outcomes?

artículo científico publicado en 2014

Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study

scientific article published on 15 January 2020

Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

article

Impact of an invasive strategy on 5 years outcome in men and women with non-ST-segment elevation acute coronary syndromes

artículo científico publicado en 2014

Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial

artículo científico publicado en 2016

Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study

artículo científico publicado en 2020

Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy

artículo científico publicado en 2014

Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study

artículo científico publicado en 2006

Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission

artículo científico publicado en 2007

Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers

artículo científico publicado en 2006

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.

artículo científico publicado en 2017

Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes

artículo científico publicado en 2008

Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers

artículo científico publicado en 2010

In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events

artículo científico publicado en 2020

Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome

artículo científico publicado en 2018

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A COllaboration between Multiple inst

scientific article published on 06 December 2020

Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

artículo científico publicado en 2017

Influence of left bundle branch block on long-term mortality in a population with heart failure

artículo científico publicado en 2007

Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommen

artículo científico publicado en 2009

Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes

scientific article published on 01 September 2007

Influence on coagulation activity by subcutaneous LMW heparin as an adjuvant treatment to fibrinolysis in acute myocardial infarction

artículo científico publicado en 2002

Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy

artículo científico publicado en 2010

Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial

scientific article published on 01 April 2019

Interleukin-18 in patients with acute coronary syndromes

artículo científico publicado en 2019

Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation

artículo científico publicado en 2015

International differences in treatment effect: do they really exist and why?

artículo científico publicado en 2013

Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial

artículo científico publicado en 2012

Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy

artículo científico publicado en 2017

Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators

artículo científico publicado en 2001

Is patient involvement during hospitalization for acute myocardial infarction associated with post-discharge treatment outcome? An exploratory study

artículo científico publicado en 2010

Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study

artículo científico publicado en 2018

Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy

artículo científico

Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases

artículo científico publicado en 2016

Large-scale association analysis identifies new risk loci for coronary artery disease

artículo científico publicado en 2012

Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial

artículo científico

Letter by Damman et al regarding articles, "Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual pat

artículo científico publicado en 2012

Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2016

Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients

artículo científico publicado en 2007

Long-Term Low-Molecular-Weight Heparin (Fragmin) and/or Early Revascularization During Instability in Coronary Artery Disease (the FRISC II Study) ⬇️

artículo científico publicado el 4 de septiembre de 1997

Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina: One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial

artículo científico publicado en 2003

Long-term Outcome of Primary Percutaneous Coronary Intervention vs Prehospital and In-Hospital Thrombolysis for Patients With ST-Elevation Myocardial Infarction

artículo científico publicado en 2006

Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA

artículo científico publicado en 2011

Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation

artículo científico publicado en 2016

Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data

artículo científico publicado en 2010

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden

artículo científico publicado en 2007

Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden

artículo científico publicado en 2009

Long-term treatment with ximelagatran, an oral direct thrombin inhibitor, persistently reduces the coagulation activity after a myocardial infarction

artículo científico publicado en 2005

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction—the ASSENT Plus study ⬇️

artículo científico publicado el 1 de mayo de 2003

Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC). FRISC Study Group

artículo científico publicado en 1997

Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus

artículo científico publicado en 2002

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

artículo científico publicado en 2013

Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome

artículo científico publicado en 2019

Lp-PLA2, scavenger receptor class B type I gene (SCARB1) rs10846744 variant, and cardiovascular disease

artículo científico publicado en 2018

Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization

artículo científico

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

article

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures

artículo científico publicado en 2014

Management and outcomes of major bleeding during treatment with dabigatran or warfarin

artículo científico

Management strategies for a better outcome in unstable coronary artery disease

artículo científico publicado en 1998

Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD Council

artículo científico publicado en 1999

Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy

artículo científico publicado en 2001

Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).

artículo científico publicado en 2010

Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.

artículo científico publicado en 2009

Meta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or Ticagrelor

artículo científico publicado en 2020

Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes

artículo científico publicado en 2015

Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline

artículo científico publicado en 2020

Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)

artículo científico publicado en 2021

Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease

artículo científico publicado en 2004

Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial

artículo científico publicado en 2012

N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

artículo científico publicado en 2013

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte

artículo científico publicado en 2003

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease

artículo científico publicado en 2003

NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO).

artículo científico publicado en 2015

NT-ProBNP in non-ST-elevation acute coronary syndrome

artículo científico publicado en 2005

NT-proBNP in unstable coronary artery disease--experiences from the FAST, GUSTO IV and FRISC II trials

artículo científico publicado en 2004

Natriuretic peptide should be used as a routine tool for evaluation of patients with atrial fibrillation

artículo científico publicado en 2018

Natriuretic peptides in unstable coronary artery disease

artículo científico publicado en 2004

New generation cardiac troponin I assay for the access immunoassay system

scientific article published on 01 May 2001

New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis

artículo científico publicado en 2013

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper

artículo científico publicado en 2012

Newly identified events in the RE-LY trial

artículo científico publicado en 2010

Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics

artículo científico publicado en 2020

Niemann-Pick C1 modulates hepatic triglyceride metabolism and its genetic variation contributes to serum triglyceride levels

artículo científico publicado en 2010

No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded Trials

scientific article published on 01 April 2020

No misrepresentation of vital status follow-up in PLATO: predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial: Commentary on: DiNicolantonio JJ, Tomek A, Misrepresentation of vital status foll

artículo científico publicado en 2014

No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial

artículo científico publicado en 2007

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation

artículo científico publicado en 2016

Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group

artículo científico publicado en 1997

Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial

article published in 2018

Observer variability and optimal criteria of transient ischemia during ST monitoring with continuous 12-lead ECG

scientific article published on 01 July 2002

Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study

artículo científico publicado en 2016

Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease

artículo científico publicado en 2016

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

artículo científico publicado en 2003

Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

artículo científico publicado en 2018

Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients—Results from the PLATelet inhibition and patient Outcomes (PLATO) study

scientific article published on 17 October 2012

Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease

artículo científico publicado en 2000

Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial

artículo científico publicado en 2004

Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab

artículo científico publicado en 2003

Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial b

artículo científico publicado en 2016

Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease

artículo científico publicado en 2018

Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry

artículo científico publicado en 2016

Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial

scientific article published on 22 November 2018

Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial

artículo científico publicado en 2013

Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease

artículo científico publicado en 2005

P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.

scientific article published on 24 July 2009

PROTEIN-CODING VARIANTS IMPLICATE NOVEL GENES RELATED TO LIPID HOMEOSTASIS CONTRIBUTING TO BODY FAT DISTRIBUTION

article

Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease

artículo científico publicado en 2013

Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome

artículo científico publicado en 2008

Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial

scientific article published on 21 November 2019

Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes

artículo científico publicado en 2006

Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo

artículo científico publicado en 2008

Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial

scientific article published on 24 April 2019

Percutaneous Coronary Intervention vs Thrombolysis for ST-Elevation Myocardial Infarction—Reply

artículo científico publicado en 2007

Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial

artículo científico publicado en 2017

Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation

artículo científico

Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors

artículo científico publicado en 2014

Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.

artículo científico publicado en 2014

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial

artículo científico

Persistence of the prothrombotic state after acute coronary syndromes: implications for treatment

artículo científico publicado en 2002

Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality

artículo científico publicado en 2007

Persistent inhibition of platelet function during long-term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery disease

artículo científico publicado en 1991

Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors ⬇️

artículo científico publicado en 2017

Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib

artículo científico publicado en 2017

Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2017

Physical activity in patients with stable coronary heart disease: an international perspective

artículo científico publicado en 2013

Plasma fibrinogen in unstable coronary artery disease

artículo científico publicado en 1989

Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals

artículo científico publicado en 2016

Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome.

artículo científico

Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study

article

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

artículo científico publicado en 2016

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial

scientific article published on 01 November 2011

Population pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in aspirin-treated patients with stable coronary artery disease

artículo científico publicado en 2008

Possible reasons for the prognostic value of troponin-T on admission in patients with ST-elevation myocardial infarction

scientific article published on 01 May 2001

Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI

scientific article published on 01 July 2020

Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials

artículo científico publicado en 2017

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

artículo científico publicado en 2007

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

artículo científico publicado en 2006

Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile

artículo científico publicado en 2007

Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction

scientific article published on 19 April 2006

Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

artículo científico publicado en 2020

Prehospital diagnosis and start of treatment reduces time delay and mortality in real-life patients with STEMI.

artículo científico publicado en 2005

Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation

artículo científico publicado en 2020

Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2019

Prevention of cardiovascular events after acute coronary syndrome

artículo científico publicado en 2005

Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia. The Research Group on Instability in Coronary Artery Disease in Southeast Sweden

artículo científico publicado el 29 de agosto de 1992

Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

article

Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice

artículo científico publicado en 2004

Prognostic Value of Ischemia Monitoring with On-Line Vectorcardiography in Patients with Unstable Coronary Artery Disease

scholarly article by Peter Lundin et al published 2000 in Cardiology

Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.

artículo científico publicado en 2018

Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel

scientific article published on 23 December 2019

Prognostic importance of early exercise testing in men with suspected unstable coronary artery disease

artículo científico publicado en 1987

Prognostic relevance of PCI-related myocardial infarction.

artículo científico publicado en 2013

Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study).

artículo científico publicado en 2013

Prognostic value of ST-segment resolution-when and what to measure

artículo científico publicado en 2003

Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome

artículo científico publicado en 2009

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome

artículo científico publicado en 2007

Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

artículo científico publicado en 2017

Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution

article

ProteinSeq: high-performance proteomic analyses by proximity ligation and next generation sequencing

artículo científico publicado en 2011

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

artículo científico publicado en 2017

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

artículo científico publicado en 2019

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.

artículo científico publicado en 2018

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.

artículo científico publicado en 2018

Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)

article

Quantitative ST-depression in acute coronary syndromes: the PLATO electrocardiographic substudy

artículo científico publicado en 2013

Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study population

artículo científico publicado en 2004

Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment

artículo científico publicado en 2003

Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome

artículo científico publicado en 2008

Rapid Endovascular Catheter Core Cooling Combined With Cold Saline as an Adjunct to Percutaneous Coronary Intervention for the Treatment of Acute Myocardial Infarction

artículo científico publicado en 2014

Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

artículo científico publicado en 2009

Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.

artículo científico

Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.

artículo científico publicado en 2014

Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial

scientific article published on 30 December 2019

Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register

artículo científico publicado en 2009

Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group

artículo científico publicado en 1996

Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

scientific article published on 01 November 2018

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

artículo científico publicado en 2017

Relations of growth-differentiation factor-15 to biomarkers reflecting vascular pathologies in a population-based sample of elderly subjects

artículo científico publicado en 2011

Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

artículo científico

Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes

artículo científico publicado en 2009

Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study

artículo científico publicado en 2011

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

artículo científico publicado en 2001

Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trial

artículo científico publicado en 2017

Renal Function in Atrial Fibrillation: A Multifaceted Dilemma

artículo científico publicado en 2016

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time

artículo científico publicado en 2017

Reply to Letters Regarding Article, “Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Tria

Reply: Anticoagulant-Related Nephropathy

scientific article published on 01 December 2015

Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed

artículo científico publicado en 2018

Reply: Higher N-terminal Pro-B-type natriuretic peptide may be related to very different conditions

artículo científico publicado en 2013

Reply: regarding the effect of dabigatran plasma concentrations

artículo científico publicado en 2014

Response to letter regarding article, "Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy".

artículo científico publicado en 2013

Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study"

artículo científico publicado en 2014

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

artículo científico publicado en 2014

Response to letter regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial a

artículo científico publicado en 2014

Response to letter regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin"

artículo científico publicado en 2014

Response to letter regarding article, "Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial".

artículo científico publicado en 2014

Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials".

artículo científico publicado en 2013

Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.

artículo científico publicado en 2013

Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudication

artículo científico publicado en 2013

Risk Markers of Incident Atrial Fibrillation in Patients with Coronary Heart Disease

scientific article published on 02 January 2021

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

artículo científico

Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group

artículo científico publicado en 1997

Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial

artículo científico publicado en 2011

Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials

artículo científico publicado en 2005

ST Elevation Acute Coronary Syndromes in PLATO

article

ST resolution 1 hour after fibrinolysis for prediction of myocardial infarct size: insights from ASSENT 3.

artículo científico publicado en 2008

ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction

artículo científico publicado en 2003

ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy

artículo científico

ST-segment analyses and residual thrombi in the infarct-related artery: a report from the ASSENT PLUS ST-monitoring substudy

artículo científico publicado en 2004

ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction

artículo científico publicado en 1999

ST2 and mortality in non-ST-segment elevation acute coronary syndrome

artículo científico publicado en 2010

Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes

artículo científico publicado en 2002

Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention

artículo científico publicado en 2016

Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis

artículo científico publicado en 2018

Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction

artículo científico publicado en 2002

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation

scientific article published on 09 December 2020

Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

artículo científico publicado en 2012

Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2017

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy

artículo científico publicado en 2005

Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials

artículo científico publicado en 2020

Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

artículo científico publicado en 2017

Sex, age, and clinical presentation of acute coronary syndromes

artículo científico publicado en 2004

Sharing Data from Cardiovascular Clinical Trials--A Proposal

artículo científico publicado en 2016

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation

artículo científico publicado en 2008

Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers

artículo científico publicado en 2006

Should the exercise test (ET) be performed at discharge or one month later after an episode of unstable angina or non-Q-wave myocardial infarction? ⬇️

artículo científico publicado el 1 de enero de 1991

Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes: from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapi

artículo científico publicado en 2011

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

artículo científico publicado en 1999

Smoking in relation to ST-segment elevation acute myocardial infarction: findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions

artículo científico publicado en 2009

Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome

artículo científico publicado en 2006

Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes

article

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

artículo científico publicado en 2018

Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease

scientific article published on 02 January 2021

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

artículo científico publicado en 2010

Subsequent Event Risk in Individuals With Established Coronary Heart Disease

artículo científico publicado en 2019

Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

artículo científico publicado en 2016

Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry

scientific article published on 01 February 2020

The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial.

artículo científico publicado en 2016

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

artículo científico publicado en 2016

The ABC risk score for patients with atrial fibrillation - Authors' reply.

artículo científico publicado en 2016

The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice

artículo científico publicado en 2004

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

artículo científico publicado en 2013

The PLATO trial reveals further opportunities to improve outcomes in patients with acute coronary syndrome. Editorial on Serebruany. "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011;

artículo científico publicado en 2011

The SCAAR-scare in perspective.

artículo científico publicado en 2009

The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART).

artículo científico publicado en 2010

The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease

artículo científico publicado en 1999

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

artículo científico publicado en 2013

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2014

The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electroca

artículo científico publicado en 2011

The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: the ASSENT PLUS study

artículo científico publicado en 2001

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.

artículo científico publicado en 2016

The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease ⬇️

artículo científico publicado el 1 de febrero de 1992

The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy

artículo científico publicado en 2002

The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial

artículo científico publicado en 2008

The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004

artículo científico publicado en 2006

Therapeutic hypothermia for the treatment of acute myocardial infarction-combined analysis of the RAPID MI-ICE and the CHILL-MI trials

artículo científico publicado en 2015

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

artículo científico publicado en 2011

Thrombolysis with recombinant human tissue-type plasminogen activator during instability in coronary artery disease: effect on myocardial ischemia and need for coronary revascularization. TRIC Study Group

artículo científico publicado en 1992

Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes

artículo científico publicado en 2012

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery

article

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial

artículo científico publicado en 2015

Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial

artículo científico

Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial

artículo científico publicado en 2014

Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials

artículo científico publicado en 2013

Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2019

Ticagrelor treatment in patients with acute coronary syndrome is cost-effective in Sweden and Denmark

artículo científico publicado en 2014

Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial

artículo científico publicado en 2015

Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial

artículo científico

Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis

artículo científico publicado en 2010

Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2011

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2010

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

artículo científico publicado en 2014

Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial

artículo científico publicado en 2005

Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trial

artículo científico publicado en 2017

Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Insta

artículo científico publicado en 2012

Tooth loss is independently associated with poor outcomes in stable coronary heart disease

artículo científico publicado en 2015

Towards a new order in cardiovascular medicine: re-engineering through global collaboration

article

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

artículo científico publicado en 2017

Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction ⬇️

artículo científico publicado el 23 de febrero de 2011

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial

artículo científico publicado en 2003

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction

artículo científico publicado en 2002

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

artículo científico publicado en 2003

Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy

artículo científico publicado en 2006

Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction

artículo científico publicado en 2003

Understanding the use of observational and randomized data in cardiovascular medicine

scientific article published on 04 February 2020

Unraveling the spectrum of left bundle branch block in acute myocardial infarction: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials

artículo científico publicado en 2006

Unreliable Observations from a Confounded Analysis of a Skewed Database

Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial

artículo científico publicado en 2016

Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation

artículo científico publicado en 2018

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

artículo científico publicado en 2016

Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).

artículo científico publicado en 2014

Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).

artículo científico publicado en 2005

Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials).

artículo científico publicado en 2011

Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients’ value

article

Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial

artículo científico publicado en 2016

Variants of the Interferon Regulatory Factor 5 Gene Regulate Expression of IRF5 mRNA in Atherosclerotic Tissue But Are Not Associated With Myocardial Infarction

article

Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulati

artículo científico

Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry.

artículo científico publicado en 2014

Variations in pre-hospital fibrinolysis process of care: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic 3 Plus international acute myocardial infarction pre-hospital care survey

artículo científico publicado en 2004

Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial

artículo científico publicado en 2017

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease

scientific article published on 14 November 2013

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

artículo científico publicado en 2013

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial

artículo científico publicado en 2014

Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial.

artículo científico publicado en 2014

Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes

artículo científico publicado en 2010

Why don't we return to bare metal stents?

artículo científico publicado en 2008

Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA).

artículo científico publicado en 2008

[Care of myocardial infarction strongly improved 1995-2005. Quality registry, open statements and clear therapeutic goals have payed off]

artículo científico publicado en 2007

[Emergency coronary care--successful, but unequaly distributed]

scientific article published on 01 June 1998

[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]

artículo científico publicado en 2004

[Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes].

artículo científico publicado en 2008

[Policy document. Catheter-based diagnosis and treatment of coronary diseases]

scientific article published on 01 January 2001

[Riks-HIA will develop a new index for areas with room for improvement]

artículo científico publicado en 2012

[Swedish work with national guidelines can become an international model. With perspectives from cardiovascular diseases guidelines]

artículo científico publicado en 2008

[Use of percutaneous coronary vessel interventions should be increased. 400 interventions per year is a minimum capacity of decentralized services]

artículo científico publicado en 1999

Lista de obras de Lars Wallentin

2008 National Cardiology Guidelines: Prioritization requires consideration to other factors than scientific studies alone

5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

A catalog of genetic loci associated with kidney function from analyses of a million individuals

A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy

A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors

A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes

ABSTRACTS

ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial

Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy

Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST–elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy11Guest Editor for this manuscript

Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK.

Additional events in the RE-LY trial

Additional value of thallium-201 SPECT to a conventional exercise test for the identification of severe coronary lesions after an episode of unstable coronary artery disease

Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes

Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction

Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction

Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey

Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome

Ambulatory ST-recording has no additional value to exercise test for identification of severe coronary lesions after an episode of unstable coronary artery disease in men

Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial

An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease

An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study

Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial

Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies

Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

Antibodies against MYC-Associated Zinc Finger Protein: An Independent Marker in Acute Coronary Syndrome?

Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial

Anticoagulants in heart disease: current status and perspectives

Anticoagulation Therapy in Atrial Fibrillation in Combination With Acute Myocardial Infarction Influences Long-Term Outcome

Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial

Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?

Antithrombotic Therapy Use and Clinical Outcomes Following Thromboembolic Events in Patients with Atrial Fibrillation: Insights from ARISTOTLE.

Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005.

Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis.

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative

Antithrombotics in acute coronary syndromes

Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial

Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trial

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

Apixaban with antiplatelet therapy after acute coronary syndrome

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation

Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis

Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction

Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction

Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation

Association of Factor V Leiden with Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data

Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study

Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial

Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS

Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial

Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention

Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy

Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation

Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes